This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-let-7a-5p | CCR7 | 0.62 | 3.0E-5 | 0.43 | 0.49465 | miRTarBase; TargetScan; miRNATAP | -0.61 | 0.00343 | 22251626 | In the present study the authors demonstrated that microRNA miRNA let-7a downregulates CCR7 expression and directly influences the migration and invasion of breast cancer cells; The expression of CCR7 its ligand CCL21 and let-7a was detected in breast cancer cell lines and in breast cancer patient tissues; To confirm the fact that 3'UTR of CCR7 is a direct target of let-7a a luciferase assay for the reporter gene expressing the let-7a binding sites of CCR7 3'UTR was used; In addition a reverse correlation in the expression of CCR7 and let-7a in breast cancer cell lines and breast cancer patient tissues was detected; Synthetic let-7a decreased breast cancer cell proliferation migration and invasion as well as CCR7 protein expression in MDA-MB-231 cells; The 3'UTR of CCR7 was confirmed as a direct target of let-7a by using the luciferase assay for the reporter gene expressing let-7a CCR7 3'UTR binding sites; The results from the present study suggest that targeting of CCL21-CCR7 signaling is a valid approach for breast cancer therapy and that let-7a directly binds to the 3'UTR of CCR7 and blocks its protein expression thereby suppressing migration and invasion of human breast cancer cells |
2 | hsa-let-7b-5p | CCR7 | 0.6 | 0.0014 | 0.43 | 0.49465 | miRNATAP | -0.68 | 2.0E-5 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | REGULATION OF INTERFERON BETA PRODUCTION | 5 | 44 | 7.853e-09 | 1.443e-05 |
2 | POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS | 12 | 867 | 4.136e-09 | 1.443e-05 |
3 | REGULATION OF IMMUNE SYSTEM PROCESS | 14 | 1403 | 9.301e-09 | 1.443e-05 |
4 | CELLULAR RESPONSE TO ORGANIC SUBSTANCE | 15 | 1848 | 3.575e-08 | 4.159e-05 |
5 | IMMUNE SYSTEM PROCESS | 15 | 1984 | 9.252e-08 | 7.175e-05 |
6 | POSITIVE REGULATION OF DEFENSE RESPONSE | 8 | 364 | 8.007e-08 | 7.175e-05 |
7 | POSITIVE REGULATION OF INTERFERON BETA PRODUCTION | 4 | 30 | 1.436e-07 | 9.17e-05 |
8 | REGULATION OF RESPONSE TO STRESS | 13 | 1468 | 1.577e-07 | 9.17e-05 |
9 | POSITIVE REGULATION OF RESPONSE TO STIMULUS | 14 | 1929 | 5.075e-07 | 0.0002544 |
10 | REGULATION OF IMMUNE RESPONSE | 10 | 858 | 5.467e-07 | 0.0002544 |
11 | PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 5 | 109 | 7.851e-07 | 0.0003321 |
12 | REGULATION OF TYPE I INTERFERON PRODUCTION | 5 | 111 | 8.593e-07 | 0.0003332 |
13 | POSITIVE REGULATION OF INFLAMMATORY RESPONSE | 5 | 113 | 9.39e-07 | 0.0003361 |
14 | REGULATION OF CELL DEATH | 12 | 1472 | 1.362e-06 | 0.0004528 |
15 | POSITIVE REGULATION OF CYTOKINE PRODUCTION | 7 | 370 | 1.583e-06 | 0.0004911 |
16 | REGULATION OF CYTOKINE PRODUCTION | 8 | 563 | 2.173e-06 | 0.0005056 |
17 | POSITIVE REGULATION OF CELL COMMUNICATION | 12 | 1532 | 2.078e-06 | 0.0005056 |
18 | DEFENSE RESPONSE | 11 | 1231 | 1.782e-06 | 0.0005056 |
19 | POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION | 3 | 16 | 2.054e-06 | 0.0005056 |
20 | POSITIVE REGULATION OF IMMUNE RESPONSE | 8 | 563 | 2.173e-06 | 0.0005056 |
21 | REGULATION OF INTERFERON ALPHA PRODUCTION | 3 | 19 | 3.543e-06 | 0.000785 |
22 | CELLULAR RESPONSE TO CYTOKINE STIMULUS | 8 | 606 | 3.75e-06 | 0.0007932 |
23 | POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION | 4 | 70 | 4.595e-06 | 0.0009295 |
24 | RESPONSE TO NITROGEN COMPOUND | 9 | 859 | 5.483e-06 | 0.001029 |
25 | POSITIVE REGULATION OF RESPONSE TO WOUNDING | 5 | 162 | 5.53e-06 | 0.001029 |
26 | POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 11 | 1395 | 6.005e-06 | 0.001075 |
27 | POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 6 | 296 | 6.548e-06 | 0.001128 |
28 | RESPONSE TO LIPID | 9 | 888 | 7.177e-06 | 0.001193 |
29 | TOLL LIKE RECEPTOR SIGNALING PATHWAY | 4 | 85 | 9.977e-06 | 0.001419 |
30 | REGULATION OF MYELOID CELL DIFFERENTIATION | 5 | 183 | 1.001e-05 | 0.001419 |
31 | REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 9 | 926 | 1.006e-05 | 0.001419 |
32 | REGULATION OF HEMOPOIESIS | 6 | 314 | 9.172e-06 | 0.001419 |
33 | RESPONSE TO ORGANIC CYCLIC COMPOUND | 9 | 917 | 9.303e-06 | 0.001419 |
34 | REGULATION OF PROTEOLYSIS | 8 | 711 | 1.209e-05 | 0.001655 |
35 | RESPONSE TO CYTOKINE | 8 | 714 | 1.247e-05 | 0.001658 |
36 | MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 3 | 30 | 1.467e-05 | 0.001896 |
37 | ACTIVATION OF INNATE IMMUNE RESPONSE | 5 | 204 | 1.692e-05 | 0.002128 |
38 | REGULATION OF DEFENSE RESPONSE | 8 | 759 | 1.94e-05 | 0.002286 |
39 | INTRACELLULAR SIGNAL TRANSDUCTION | 11 | 1572 | 1.873e-05 | 0.002286 |
40 | POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION | 3 | 33 | 1.965e-05 | 0.002286 |
41 | POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 9 | 1036 | 2.467e-05 | 0.002733 |
42 | POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 9 | 1036 | 2.467e-05 | 0.002733 |
43 | CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 8 | 799 | 2.806e-05 | 0.003037 |
44 | REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 11 | 1656 | 3.052e-05 | 0.003228 |
45 | REGULATION OF PEPTIDASE ACTIVITY | 6 | 392 | 3.212e-05 | 0.003321 |
46 | RESPONSE TO PEPTIDE | 6 | 404 | 3.801e-05 | 0.003837 |
47 | CYTOKINE PRODUCTION | 4 | 120 | 3.892e-05 | 0.003837 |
48 | IMMUNE RESPONSE | 9 | 1100 | 3.958e-05 | 0.003837 |
49 | POSITIVE REGULATION OF INNATE IMMUNE RESPONSE | 5 | 246 | 4.15e-05 | 0.00394 |
50 | REGULATION OF RESPONSE TO WOUNDING | 6 | 413 | 4.298e-05 | 0.004 |
51 | NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 3 | 43 | 4.396e-05 | 0.004011 |
52 | REGULATION OF NEURON DEATH | 5 | 252 | 4.654e-05 | 0.004164 |
53 | LEUKOCYTE MIGRATION | 5 | 259 | 5.301e-05 | 0.004485 |
54 | NEGATIVE REGULATION OF CELL DEATH | 8 | 872 | 5.229e-05 | 0.004485 |
55 | ACTIVATION OF IMMUNE RESPONSE | 6 | 427 | 5.174e-05 | 0.004485 |
56 | POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 8 | 876 | 5.402e-05 | 0.004488 |
57 | RESPONSE TO BIOTIC STIMULUS | 8 | 886 | 5.853e-05 | 0.004778 |
58 | RESPONSE TO HORMONE | 8 | 893 | 6.187e-05 | 0.004963 |
59 | REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY | 3 | 49 | 6.52e-05 | 0.005056 |
60 | POSITIVE REGULATION OF CHEMOKINE PRODUCTION | 3 | 49 | 6.52e-05 | 0.005056 |
61 | POSITIVE REGULATION OF BIOSYNTHETIC PROCESS | 11 | 1805 | 6.772e-05 | 0.005165 |
62 | CELLULAR RESPONSE TO PEPTIDE | 5 | 274 | 6.921e-05 | 0.005194 |
63 | RESPONSE TO EXTERNAL STIMULUS | 11 | 1821 | 7.342e-05 | 0.005264 |
64 | INFLAMMATORY RESPONSE | 6 | 454 | 7.267e-05 | 0.005264 |
65 | REGULATION OF INTERLEUKIN 12 PRODUCTION | 3 | 51 | 7.354e-05 | 0.005264 |
66 | CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND | 6 | 465 | 8.293e-05 | 0.005847 |
67 | POSITIVE REGULATION OF TRANSPORT | 8 | 936 | 8.61e-05 | 0.005979 |
68 | PHOSPHORYLATION | 9 | 1228 | 9.319e-05 | 0.006376 |
69 | REGULATION OF INFLAMMATORY RESPONSE | 5 | 294 | 9.648e-05 | 0.006506 |
70 | IMMUNE EFFECTOR PROCESS | 6 | 486 | 0.0001057 | 0.007027 |
71 | MOVEMENT OF CELL OR SUBCELLULAR COMPONENT | 9 | 1275 | 0.0001243 | 0.008148 |
72 | POSITIVE REGULATION OF HEMOPOIESIS | 4 | 163 | 0.000128 | 0.008239 |
73 | DEFENSE RESPONSE TO VIRUS | 4 | 164 | 0.000131 | 0.008239 |
74 | CELLULAR RESPONSE TO NITROGEN COMPOUND | 6 | 505 | 0.0001304 | 0.008239 |
75 | POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 2 | 11 | 0.0001352 | 0.008387 |
76 | INTRACELLULAR RECEPTOR SIGNALING PATHWAY | 4 | 168 | 0.0001438 | 0.008802 |
77 | GLUCOSE HOMEOSTASIS | 4 | 170 | 0.0001505 | 0.008948 |
78 | REGULATION OF CHEMOKINE PRODUCTION | 3 | 65 | 0.0001519 | 0.008948 |
79 | CARBOHYDRATE HOMEOSTASIS | 4 | 170 | 0.0001505 | 0.008948 |
80 | REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 4 | 172 | 0.0001574 | 0.009154 |
81 | NEGATIVE REGULATION OF PROTEOLYSIS | 5 | 329 | 0.0001634 | 0.009269 |
82 | I KAPPAB PHOSPHORYLATION | 2 | 12 | 0.0001621 | 0.009269 |
83 | REGULATION OF HYDROLASE ACTIVITY | 9 | 1327 | 0.0001686 | 0.009452 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | hsa04062_Chemokine_signaling_pathway | 6 | 189 | 4.859e-07 | 5.077e-05 | |
2 | hsa04620_Toll.like_receptor_signaling_pathway | 5 | 102 | 5.642e-07 | 5.077e-05 | |
3 | hsa04622_RIG.I.like_receptor_signaling_pathway | 3 | 71 | 0.0001975 | 0.01185 | |
4 | hsa04914_Progesterone.mediated_oocyte_maturation | 3 | 87 | 0.00036 | 0.0162 | |
5 | hsa04722_Neurotrophin_signaling_pathway | 3 | 127 | 0.001084 | 0.03903 | |
6 | hsa04630_Jak.STAT_signaling_pathway | 3 | 155 | 0.00192 | 0.05761 | |
7 | hsa04150_mTOR_signaling_pathway | 2 | 52 | 0.003129 | 0.08045 | |
8 | hsa00010_Glycolysis_._Gluconeogenesis | 2 | 65 | 0.004844 | 0.1088 | |
9 | hsa04115_p53_signaling_pathway | 2 | 69 | 0.005442 | 0.1088 | |
10 | hsa04971_Gastric_acid_secretion | 2 | 74 | 0.006235 | 0.1122 | |
11 | hsa04012_ErbB_signaling_pathway | 2 | 87 | 0.008524 | 0.1395 | |
12 | hsa04670_Leukocyte_transendothelial_migration | 2 | 117 | 0.01501 | 0.2251 | |
13 | hsa04151_PI3K_AKT_signaling_pathway | 3 | 351 | 0.01825 | 0.2457 | |
14 | hsa04650_Natural_killer_cell_mediated_cytotoxicity | 2 | 136 | 0.01993 | 0.2457 | |
15 | hsa04910_Insulin_signaling_pathway | 2 | 138 | 0.02048 | 0.2457 | |
16 | hsa04145_Phagosome | 2 | 156 | 0.02573 | 0.2895 | |
17 | hsa04510_Focal_adhesion | 2 | 200 | 0.04056 | 0.3464 | |
18 | hsa04014_Ras_signaling_pathway | 2 | 236 | 0.05455 | 0.4269 |